Sheri R. Colberg, PhD, and Michael C. Riddell, PhD EXERCISE WITH COMPLICATIONS OR OTHER HEALTH CONDITIONS: Relative and Absolute Contraindications The ADA and others have stressed the importance of appropriate screening procedures to clear patients for participation in exercise.157–164 For patients with T1D, all of the diabetes-associated complications (microvascular and …

by Dr. Sheri Colberg, Ph.D., FACSM Most of the best physical activities don’t require a gym membership, and you certainly don’t have to be able to run a marathon to gain health benefits that will allow you to live a long and healthy life, with or without diabetes.

FDA Denies Empagliflozin Approval (See this week’s Item #8.) Bydureon Pen Approved (See this week’s Item #3.)

Go4Life Guide for Older Patients  This 120-page guide from National Institute on Aging (NIH) describes the benefits of exercise and physical activity for older patients, and includes sample exercises for endurance, strength, balance, and flexibility as well as a list of resources. Go4Life was designed to help adults 50 and older incorporate …

The TAO WellShell  A Device That Brings Exercising to Planes and Couches. Now your patients can exercise anywhere. One of the hardest parts about exercising is the "getting-up factor" — going to the gym, moving from the couch. But a tiny new gadget makes it possible to work out anywhere …

The risk for type II endometrial cancer was not increased by any of the dietary items included in the analysis, according to the researchers. Women in the highest quintile of sugar-sweetened beverage consumption had a 78% higher risk for endometrial cancer compared with women who did not consume the beverages. …

The White House wants to add 1 more year to a provision of the Affordable Care Act that raises Medicaid reimbursement to Medicare levels for evaluation and management services, and for vaccination administration performed by primary care physicians. The act authorized this parity in Medicaid-Medicare pay for 2013 and 2014 …

Quality issues in the manufacturing plant prevents FDA from final approval. The investigational type 2 diabetes drug empagliflozin won’t win the FDA’s approval until "previously observed deficiencies" at a manufacturing plant are fixed. Eli Lilly and its partner, Boehringer Ingelheim, said the FDA had issued a complete response letter in …

U.S. and European regulators have found no compelling evidence of a link between the drug class which includes GLP-1 analogs and DPP-4 inhibitors, and pancreas problems or pancreatic cancer…. 

Women disproportionately affected by stroke but cause is unknown….